|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Micafungin sodium]] |
| {{Micafungin}}
| |
| '''''For patient information, click <u>[[Micafungin (patient information)|here]]</u>'''''.
| |
| | |
| {{CMG}}; {{AE}} {{AZ}}
| |
| | |
| ==Overview==
| |
| | |
| ==Category==
| |
| Antifungal drug
| |
| ==US Brand Names==
| |
| '''Mycamine<sup>®</sup>'''
| |
| ==FDA Package Insert==
| |
| | |
| ''' [[Micafungin description|Description]]'''
| |
| '''| [[Micafungin clinical pharmacology|Clinical Pharmacology]]'''
| |
| '''| [[Micafungin microbiology|Microbiology]]'''
| |
| '''| [[Micafungin indications and usage|Indications and Usage]]'''
| |
| '''| [[Micafungin contraindications|Contraindications]]'''
| |
| '''| [[Micafungin warnings and precautions|Warnings and Precautions]]'''
| |
| '''| [[Micafungin adverse reactions|Adverse Reactions]]'''
| |
| '''| [[Micafungin drug interactions|Drug Interactions]]'''
| |
| '''| [[Micafungin overdosage|Overdosage]]'''
| |
| '''| [[Micafungin clinical studies|Clinical Studies]]'''
| |
| '''| [[Micafungin dosage and administration|Dosage and Administration]]'''
| |
| '''| [[Micafungin how supplied|How Supplied]]'''
| |
| '''| [[Micafungin labels and packages|Labels and Packages]]'''
| |
| | |
| ==Mechanism of Action==
| |
| Micafungin inhibits the synthesis of 1, 3-beta-D-glucan, an essential component of fungal cell walls.
| |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antibiotics]]
| |
| | |
| [[Category:Wikinfect]]
| |